Cochrane Abstracts
Rifabutin for treating pulmonary tuberculosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rifabutin for Treating Pulmonary Tuberculosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis.
Rifabutin for treating pulmonary tuberculosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis. Accessed December 3, 2024.
Rifabutin for treating pulmonary tuberculosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis
Rifabutin for Treating Pulmonary Tuberculosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rifabutin for treating pulmonary tuberculosis
ID - 433920
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433920/all/Rifabutin_for_treating_pulmonary_tuberculosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
